Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences
- 1 January 2008
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 49 (3) , 495-501
- https://doi.org/10.1080/10428190701809172
Abstract
The objective of this study was to evaluate etiology and consequences of neutropenic fever in AML patients. Two hundred and ninety neutropenic periods following chemotherapy in 84 AML patients were retrospectively evaluated. Neutropenic fever was found in 280 periods (97%). Severe sepsis developed in 35 occasions (13%) and 9 patients (11%) died due to severe sepsis. In 165 episodes with neutropenic fever (59%), the potential causative organism was found in blood cultures. Gram-negative bacteria were more commonly found in patients who developed severe sepsis (40% vs. 23%, p = 0.03). CRP after 2 – 3 days from start with fever was higher in patients with severe sepsis (190 mg/L vs. 96 mg/L, p < 0.001) but the rise in CRP rather coincided than preceded with the development of severe sepsis. Severe sepsis is associated with significant mortality in AML patients. Earlier methods than CRP are needed to predict development of severe sepsis.Keywords
This publication has 28 references indexed in Scilit:
- Long‐term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML‐92 study by the Finnish Leukaemia GroupEuropean Journal of Haematology, 2007
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Addition of cyclosporin-A to chemotherapy in secondary (post-MDS) AML in the elderly. A multicenter randomized trial of the Leukemia Working Group of the Hellenic Society of HematologyAnnals of Hematology, 2006
- Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an eastern cooperative oncology group trial (E4995)Leukemia & Lymphoma, 2005
- ACUTE MYELOID LEUKEMIA: TREATMENTOF ADULTS UNDER 60 YEARSReviews in Clinical and Experimental Hematology, 2002
- C-Reactive Protein and Fever in Neutropenic PatientsScandinavian Journal of Infectious Diseases, 2000
- A Prospective Study of Daily Measurement of C-Reactive Protein in Serum of Adults with NeutropeniaClinical Infectious Diseases, 1995
- C-Reactive Protein: A Valuable Aid for the Management of Febrile Children with Cancer and NeutropeniaClinical Infectious Diseases, 1994
- Value of measurement of C-reactive protein in febrile patients with hematological malignanciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992